Proposed Drug definition

Proposed Drug means the drug or drugs that Medco, in its Drug Interchange Solicitation, proposes to substitute for a Currently Prescribed Drug.
Sample 1Sample 2Sample 3
Proposed Drug means the drug or drugs that Medco, in its Drug Interchange
Sample 1
Proposed Drug means the drug or drugs that Caremark, in its Drug Interchange Solicitation program, proposes to interchange for an Originally Prescribed Drug.
Sample 1

Examples of Proposed Drug in a sentence

  • With respect to Medco home delivery prescriptions, within 24 hours of express verifiable authorization of a Drug Interchange by the Prescriber or dispensing the Proposed Drug, whichever is earlier, Medco shall send to the Patient a written communication (“Written Patient Drug Interchange Notice,”) and make a telephonic communication (“Telephonic Patient Drug Interchange Notice”) advising the Patient of the Prescriber’s approval of the Drug Interchange.

  • FDA, How FDA Reviews Proposed Drug Names 1, http://www fda.gov/downloads/Drugs/DrugSafety/ MedicationErrors/ucm080867.pdf (last visited Oct.

  • If PURCHASER exercises its right of first refusal with respect to the applicable Proposed Drug Product, the Proposed Drug Product shall be deemed a New Molecule and will be subject to Paragraphs 5(b)(ii) and 5(c) above.

  • Drug Dependence and Abuse Potential) Proposed: Drug dependence and abuse potential.

  • Committee Reports and Board Actions: Board of Pharmacy/Chiropractic Formulary Committee: Proposed Drug Formulary: The board received the Appeal and Opinions from the Appeals Court.

  • Cr Nolan also asked how the Proposed Drug testing program is progressing.

  • All Taxes owed by the Company and each of its Subsidiaries (except any Consolidated Period Taxes) (whether or not shown on any Tax Return) have been timely paid.

  • For clarity, (a) the ROFR Notice does not apply to Off-The-Shelf-Devices; and (b) the ROFR Notice is only required to identify the Proposed Drug Product and not any other material terms of the Proposed Supply Request or the identity of the applicable third party.

  • Proposed Drug Manufacturing Unit at Plot No.332 Sector -1, Industrial Area, Pithampur, Teh.

  • FDA, How FDA Reviews Proposed Drug Names 1, http://www.fda.gov/downloads/Drugs/DrugSafety/ MedicationErrors/ucm080867.pdf (last visited Oct.

Related to Proposed Drug

  • New drug means: (i) any drug, except a new animal drug or an animal feed bearing or containing

  • New Drug Application means a new drug application in the United States for authorization to market a product, as defined in the applicable laws and regulations and submitted to the FDA.

  • FDCA shall have the meaning ascribed to such term in Section 3.1(hh).

  • FFDCA means the United States Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., as amended from time to time, together with any rules, regulations and requirements promulgated thereunder (including all additions, supplements, extensions, and modifications thereto).

  • cosmetic product means any substance or mixture intended to be placed in contact with the external parts of the human body (epi­ dermis, hair system, nails, lips and external genital organs) or with the teeth and the mucous membranes of the oral cavity with a view exclusively or mainly to cleaning them, perfuming them, changing their appearance, protecting them, keeping them in good condition or correcting body odours;

  • Legend drug or "prescription drug" means any drug or device that has been determined to be unsafe for self- medication or any drug or device that bears or is required to bear the legend:

  • Generic Drug means a Prescription Drug that is medically equivalent to a Brand Name Drug as determined by the FDA. It meets the same standards as a Brand Name Drug for purity, safety, strength and effectiveness and is manufactured and sold under its chemical, common, or official name.

  • Covered drug means any prescription drug that:

  • Legend drugs means any drugs which are required by state

  • FDA means the United States Food and Drug Administration and any successor agency thereto.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Drug Approval Application means an application for Regulatory Approval required before commercial sale of a Product as a pharmaceutical product in a regulatory jurisdiction.

  • FDA Act means the U.S. Federal Food, Drug, and Cosmetic Act, as amended.

  • Edible cannabis product means cannabis product that is intended to be used, in whole or in part, for human consumption, including, but not limited to, chewing gum, but excluding products set forth in Division 15 (commencing with Section 32501) of the Food and Agricultural Code. An edible cannabis product is not considered food, as defined by Section 109935 of the Health and Safety Code, or a drug, as defined by Section 109925 of the Health and Safety Code.

  • low protein modified food product means a food product that is specially formulated to have less than one gram of protein per serving and is intended to be used under the direction of a Practitioner for the dietary treatment of an inherited metabolic disease, but does not include a natural food that is naturally low in protein; and

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Drug Application means a new drug application, an abbreviated drug application, or a product license application for any Product, as appropriate, as those terms are defined in the FDCA.

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • FD&C Act means the United States Federal Food, Drug and Cosmetic Act, as amended.

  • Drug addiction means a disease characterized by a

  • FDA Approval means the approval, license, clearance or authorization of the FDA necessary for the marketing and sale of a product for human use in the United States.

  • Prescription drug order means an original or new order from a practitioner for drugs, drug-related devices or treatment for a human or animal, including orders issued through collaborative care agreements. Lawful prescriptions result from a valid practitioner-patient relationship, are intended to address a legitimate medical need, and fall within the prescribing practitioner's scope of professional practice;

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).